168 related articles for article (PubMed ID: 1348297)
1. Genetic diagnosis of Gaucher's disease.
Mistry PK; Smith SJ; Ali M; Hatton CS; McIntyre N; Cox TM
Lancet; 1992 Apr; 339(8798):889-92. PubMed ID: 1348297
[TBL] [Abstract][Full Text] [Related]
2. Detection of the 1226 (Jewish) mutation for Gaucher's disease by color PCR. A means for studying the gene frequency of the disorder.
Zimran A; Kuhl WC; Beutler E
Am J Clin Pathol; 1990 Jun; 93(6):788-91. PubMed ID: 2346136
[TBL] [Abstract][Full Text] [Related]
3. Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
Lancet; 1989 Aug; 2(8659):349-52. PubMed ID: 2569551
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of 28 Gaucher disease patients: the Australasian experience.
Lewis BD; Nelson PV; Robertson EF; Morris CP
Am J Med Genet; 1994 Jan; 49(2):218-23. PubMed ID: 8116672
[TBL] [Abstract][Full Text] [Related]
5. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
[TBL] [Abstract][Full Text] [Related]
7. Gaucher disease mutations in non-Jewish patients.
Beutler E; Gelbart T
Br J Haematol; 1993 Oct; 85(2):401-5. PubMed ID: 8280613
[TBL] [Abstract][Full Text] [Related]
8. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
[TBL] [Abstract][Full Text] [Related]
9. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
Beutler E; Gelbart T; Kuhl W; Sorge J; West C
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10544-7. PubMed ID: 1961718
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of Gaucher disease: distribution of eight mutations and the complete gene deletion in 27 patients from Germany.
le Coutre P; Demina A; Beutler E; Beck M; Petrides PE
Hum Genet; 1997 Jun; 99(6):816-21. PubMed ID: 9187679
[TBL] [Abstract][Full Text] [Related]
11. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.
Mistry PK; Cox TM
J Med Genet; 1993 Nov; 30(11):889-94. PubMed ID: 8301642
[No Abstract] [Full Text] [Related]
12. Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations.
Walley AJ; Barth ML; Ellis I; Fensom AH; Harris A
J Med Genet; 1993 Apr; 30(4):280-3. PubMed ID: 8487270
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
[TBL] [Abstract][Full Text] [Related]
14. [Gaucher's and Fabry's diseases: biochemical and genetic aspects].
Caillaud C; Poenaru L
J Soc Biol; 2002; 196(2):135-40. PubMed ID: 12360742
[TBL] [Abstract][Full Text] [Related]
15. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.
Tsuji S; Martin BM; Barranger JA; Stubblefield BK; LaMarca ME; Ginns EI
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2349-52. PubMed ID: 3353383
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.
Horowitz M; Tzuri G; Eyal N; Berebi A; Kolodny EH; Brady RO; Barton NW; Abrahamov A; Zimran A
Am J Hum Genet; 1993 Oct; 53(4):921-30. PubMed ID: 8213821
[TBL] [Abstract][Full Text] [Related]
18. Novel frameshift mutation (Pro171fsX21) in neonatal type 2 Gaucher's disease.
Park HW; Lee Y; Kim GH; Lee BS; Kim KS; Yoo HW; Kim EA
Gene; 2012 Oct; 507(2):170-3. PubMed ID: 22772462
[TBL] [Abstract][Full Text] [Related]
19. Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients.
Cormand B; Vilageliu L; Balcells S; Gonzàlez-Duarte R; Chabás A; Grinberg D
Hum Mutat; 1996; 7(3):272-4. PubMed ID: 8829663
[No Abstract] [Full Text] [Related]
20. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
